Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 50, 155-161
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AR070179, GM102137, HL094463)
- NIH STTR (1R41GM123792)
This publication has 43 references indexed in Scilit:
- Drosophila Heparan Sulfate, a Novel DesignJournal of Biological Chemistry, 2012
- Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight HeparinsScience, 2011
- Evolution of glycosaminoglycansCommunicative & Integrative Biology, 2011
- Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure−Activity Relationship StudiesJournal of the American Chemical Society, 2009
- Design of biologically active heparan sulfate and heparin using an enzyme-based approachNatural Product Reports, 2009
- Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycansNature Methods, 2008
- Profiling Heparin–Chemokine Interactions Using Synthetic ToolsACS Chemical Biology, 2007
- Microarrays of Synthetic Heparin OligosaccharidesJournal of the American Chemical Society, 2006
- The sweet and sour of cancer: glycans as novel therapeutic targetsNature Reviews Cancer, 2005
- Contribution of monosaccharide residues in heparin binding to antithrombin IIIBiochemistry, 1985